看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -47.2x - -52.2x | -49.7x |
| Selected Fwd P/E Multiple | 23.4x - 25.8x | 24.6x |
| Fair Value | €17.12 - €18.93 | €18.03 |
| Upside | 11.8% - 23.5% | 17.7% |
| Benchmarks | - | Full Ticker |
| Core Laboratories Inc. | - | NYSE:CLB |
| Patterson-UTI Energy, Inc. | - | NasdaqGS:PTEN |
| RPC, Inc. | - | NYSE:RES |
| Liberty Energy Inc. | - | NYSE:LBRT |
| NOV Inc. | - | NYSE:NOV |
| Helmerich & Payne, Inc. | - | DB:HPC |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| CLB | PTEN | RES | LBRT | NOV | HPC | |||
| NYSE:CLB | NasdaqGS:PTEN | NYSE:RES | NYSE:LBRT | NYSE:NOV | DB:HPC | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | -19.7% | NM- | NM- | 52.0% | NM- | NM- | ||
| 3Y CAGR | 16.8% | NM- | 132.8% | NM- | NM- | NM- | ||
| Latest Twelve Months | 25.0% | -967.6% | -54.6% | -49.7% | -55.4% | -109.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 2.9% | -20.3% | 2.3% | 1.4% | -1.8% | -3.8% | ||
| Prior Fiscal Year | 7.2% | 5.9% | 11.9% | 11.7% | 11.6% | 14.9% | ||
| Latest Fiscal Year | 6.0% | -18.0% | 6.4% | 7.3% | 7.2% | 12.3% | ||
| Latest Twelve Months | 5.7% | -21.5% | 3.7% | 5.3% | 5.4% | -1.0% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 10.8x | 3.3x | 4.6x | 3.1x | 5.1x | 4.6x | ||
| Price / LTM Sales | 1.0x | 0.4x | 0.7x | 0.5x | 0.6x | 0.5x | ||
| LTM P/E Ratio | 17.7x | -2.1x | 19.5x | 8.5x | 10.3x | -54.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -2.1x | 10.3x | 19.5x | |||||
| Historical LTM P/E Ratio | -32.6x | -4.0x | 10.6x | |||||
| Selected P/E Multiple | -47.2x | -49.7x | -52.2x | |||||
| (x) LTM Net Income | (33) | (33) | (33) | |||||
| (=) Equity Value | 1,558 | 1,640 | 1,722 | |||||
| (/) Shares Outstanding | 99.4 | 99.4 | 99.4 | |||||
| Implied Value Range | 15.67 | 16.49 | 17.32 | |||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 13.37 | 14.07 | 14.78 | 15.32 | ||||
| Upside / (Downside) | -12.7% | -8.1% | -3.6% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CLB | PTEN | RES | LBRT | NOV | HPC | |
| Value of Common Equity | 524 | 2,238 | 1,033 | 1,846 | 4,865 | 1,785 | |
| (/) Shares Outstanding | 46.9 | 385.2 | 216.9 | 162.0 | 371.4 | 99.4 | |
| Implied Stock Price | 11.17 | 5.81 | 4.76 | 11.40 | 13.10 | 17.95 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 11.17 | 5.81 | 4.76 | 11.40 | 13.10 | 15.32 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |